Navigation Links
Sanofi-aventis Announces Good First-quarter 2009 Performance
Date:4/29/2009

main growth driver, with net sales up 15.8%.

In the United States, the end of commercialization of Copaxone(R) by sanofi-aventis effective April 1, 2008 resulted in a 5.1% drop in net sales at constant exchange rates. On a constant structure basis and at constant exchange rates, net sales rose by 5.1% on the back of an excellent performance from Lantus(R), despite destocking of some products in distribution channels.

Net sales for Other Countries region rose by 7.6%, boosted by the performance of the Human Vaccines business and by Japan. Growth in the Asia-Pacific region was 12.8%, boosted by a fine performance in China (29.8% growth). Net sales in Japan were up 13.8% at euro 510 million, driven by the success of Plavix(R), Myslee(R) and Allegra(R). Latin America posted growth of 5.7%. The Vaccines business achieved growth of 16.8% in the Other Countries region, to euro 216 million.

First-quarter 2009 financial results

Adjusted income statement excluding selected items

Sanofi-aventis generated first-quarter net sales of euro 7,107 million, an increase of 2.5% on a reported basis. Other revenues were 21.1% higher, driven by a good performance from Plavix(R) in the United States and the appreciation of the dollar.

Gross profit totaled euro 5,684 million, up 6.6% (2.4% at constant exchange rates). The ratio of cost of sales to net sales improved by 2.4 points to 24.8% due to a favorable product mix (amplified by the rise in the dollar), and to the end of the commercialization of Copaxone(R) in North America.

Research and development expenses were up 5.8% (2.8% at constant exchange rates) at euro 1,152 million. This figure includes provisions of euro 54 million associated with the discontinuation of some projects following the recently-completed review of the R&D portfolio.

Selling and gene
'/>"/>

SOURCE Sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Sanofi-Aventis and Roche/Chugais Drugs Will Dominate the Indian Colorectal Cancer Drug Market Through 2013
2. Sanofi-aventis Affirms Its Commitment to Partnering with Local Communities to Improve Hispanic and African American Health
3. Apidra(R) SoloSTAR(R), the Easy-to-Use Insulin Delivery Device from sanofi-aventis, Now Available in the United States
4. Paul Chew Appointed to sanofi-aventis U.S. Chief Science Officer/Chief Medical Officer
5. Sanofi-aventis Partners with the Hispanic Community in Miami to Increase Health Awareness, Access to Resources and Help Improve Patient Care
6. Sanofi-aventis Partners with the Hispanic Community in San Antonio to Increase Health Awareness, Access to Resources and Help Improve Patient Care
7. Sanofi-aventis Delivers 2008 Results Above Guidance
8. Sanofi-aventis Partners with the Hispanic Community in Bronx to Increase Health Awareness, Access to Resources and Help Improve Patient Care
9. Sanofi-aventis Partners with the African American Community in Memphis to Increase Health Awareness, Access to Resources and Help Improve Patient Care
10. Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
11. Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Colorado (PRWEB) February 26, 2015 As ... millions are looking for deeper meaning, more substantial roles ... question – how do I live a life that ... 10th round of Younger Next Year Total Immersion ... revealed. This program boasts unbelievable results and jump-starts a ...
(Date:2/26/2015)... 2015 “In the last few years, ... evolution of one of the newest hair restoration technologies ... offers a machinery that facilitates the extraction of ... scalp,” said Dr. Parsa Mohebi. , Although ARTAS had ... at which the device extracted these grafts could not ...
(Date:2/26/2015)... Los Angeles, CA (PRWEB) February 26, 2015 ... to live stream his hair transplant contest winner’s ... and preparation, the winner Marc R., is all set to ... transplant using the ARTAS system. His procedure will be done ... Parsa Mohebi website. To watch the surgery, go to the ...
(Date:2/26/2015)... Thousands of people in local communities nationwide ... for the Muscular Dystrophy Association during the 2015 MDA ... that will help save and improve the lives of ... Walk events unite and rally communities to raise funds ... are compromised — including everyday abilities like walking, running, ...
(Date:2/26/2015)... February 26, 2015 PartnerTech Inc . ... & Makers Awards finalist. , The Movers ... involved in the manufacturing, processing, or distribution of tangible products ... Center. This annual event serves as Georgia’s largest local ... expected to draw more than 300 local industry and business ...
Breaking Medicine News(10 mins):Health News:The Aspen Club on Actively Aging: Telling a New Story on Aging 2Health News:Newest Technology now Available at Parsa Mohebi Hair Restoration 2Health News:Hair Transplant Contest Winner’s Surgery to be Streamed LIVE 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 3Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 2Health News:PartnerTech Named a Finalist for Gwinnett County Chamber of Commerce 2015 Movers & Makers Award 3
... ordering chest CT examinations translates into positive examinations three-quarters ... study, conducted at Massachusetts General Hospital in Boston, of ... a decision support system, found that 76% of patients ... "Rising concerns about radiation risks, imaging growth and reimbursement ...
... A new analysis suggests the benefits of mammography screening ... 40 to 49 who are at an increased risk of ... out of every five American women. The researchers also ... to film mammography. These findings, with contributions from three national ...
... State University researchers have invented a protein purifier that ... The details of the invention, which appear in a ... that MSU chemists Merlin Bruening and Greg Baker,s high-performance ... step in the development of some new drugs. ...
... Dotinga HealthDay Reporter , MONDAY, April 30 (HealthDay ... a commonly used insecticide to unusual changes in the brain ... that the pesticide is at fault. The findings ... as chlorpyrifos, which is used to treat farm products in ...
... officer calling for backup while also keeping a strong hold ... a two-tier approach to fighting off a threat, new research ... the first time, the scientists managed to capture that reaction ... model of virus-infected brain cells, while also sending signals to ...
... Control and Prevention (CDC) found that one-third of U.S. adults ... depression. According to findings that appear today in Arthritis ... behalf of the American College of Rheumatology (ACR), anxiety is ... despite more clinical focus on the latter mental health condition. ...
Cached Medicine News:Health News:Research examines when benefits of screening mammography outweigh the harms for women in their 40s 2Health News:Research examines when benefits of screening mammography outweigh the harms for women in their 40s 3Health News:MSU invention could help pharmaceutical industry save money 2Health News:Insecticide Linked to Brain Abnormalities in Kids 2Health News:Insecticide Linked to Brain Abnormalities in Kids 3Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 2Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 3Health News:One-third of adult Americans with arthritis battle anxiety or depression 2
(Date:2/26/2015)... , February 26, 2015 ... scroll to bottom . Investor-Edge has initiated ... JNJ ), Teva Pharmaceutical Industries Ltd (NYSE: ... ENDP ), Allergan Inc. (NYSE: AGN ... Free research report on Johnson and Johnson can be ...
(Date:2/26/2015)... -- MEI Pharma, Inc. (Nasdaq: MEIP ), an oncology ... cancer, announced today that Daniel P. Gold , Ph.D., ... and Company 35 th Annual Health Care Conference on ... the Boston Marriott Copley Place. A live webcast of the ... will be available approximately one hour after the presentation. ...
(Date:2/26/2015)...  Great Basin Scientific, Inc. ("Great Basin") announced today ... of up to 2,724,000 units at $8.80 per Unit.  ... preferred stock and eight Series C warrants.  Each share ... four shares of common stock and each Series C ... stock at an exercise price of $2.55 per share.  ...
Breaking Medicine Technology:Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 2Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 3Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 4Updates on Pharma Stocks -- Johnson and Johnson, Teva Pharma Industries, Endo Intl., Allergan, and Depomed 5MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3Great Basin Scientific, Inc. Announces Commencement of Public Offering 2Great Basin Scientific, Inc. Announces Commencement of Public Offering 3
... April 18, 2011 BB&T Capital Markets served as ... Dr. Comfort, the leading developer, manufacturer and marketer of ... its sale to DJO Global, an international provider of ... pain management based in Vista, Calif. Dr. Comfort generated ...
... April 18, 2011 ImpactRx, the pioneer in measuring ... today that Symphony Technology Group (STG), has acquired a ... leading private equity firm with a strategic focus on ... (MCV), the venture capital arm of Merck and one ...
Cached Medicine Technology:BB&T Advises Dr. Comfort on Its Sale to DJO Global in Transaction Valued at $254.6 Million 2ImpactRx Acquired by Symphony Technology Group 2ImpactRx Acquired by Symphony Technology Group 3
... anchor is generally utilized when a surgeon would ... soft tissue, or seat the anchor below the ... 4.4mm anchor is the same as what comes ... a longer, calibrated shaft to easier gauge anchor ...
The MINI-TAG™ instrument systems are indicated for ulnar collateral ligament repair, scapholunate dissolution, flexor avulsions, and carpometa-carpal arthroplasty....
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Medicine Products: